The Canada Enteral Feeding Devices Market was valued at $58.3 Million in 2025 and projected to reach to $82.1 Million by 2030, representing a compound annual growth rate of 5.0%. Canada's enteral feeding devices market is positioned for steady growth through 2030, driven by demographic shifts and healthcare system priorities.
Canada's enteral feeding devices market is valued at $58.3 million in 2025 and is projected to reach $82.1 million by 2030, growing at a CAGR of 5.0%, slightly below the global average of 5.5%.
Canada's rapidly aging demographic, with seniors comprising over 18% of the population, is significantly increasing demand for enteral feeding solutions in both institutional and home care settings.
Rising preference for home-based nutritional support and palliative care in Canada is driving adoption of portable and user-friendly enteral feeding devices among patients and caregivers.
Canada's publicly funded healthcare system and provincial reimbursement policies for enteral nutrition support are facilitating market accessibility and encouraging device adoption across regions.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | CONSUMABLES AND ACCESSORIES (Product) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 5.5% from 2025 to 2030 |
| Largest Segment | TRANSNASAL, TRANSORAL, AND PERCUTANEOUS ENDOSCOPIC INSERTION (Insertion Method) |
| Market Size Base Year (Billions) | ~USD 3.27 (2025) |
| Revenue Forecast (Billions) | ~USD 4.28 (2030) |
| Segments Covered | Product, Type, Age Group, Insertion Method, Application, End User |
6 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| WILO SE | Germany | Private Company | Building Services Residential,Building Services Commercial,Original Equipment Manufacturers, |
| FRESENIUS SE & CO. KGAA | Germany | Public Company | Helios hospitals and care delivery,Injectable generics and IV fluids,Clinical nutrition (enteral and parenteral), |
| CARDINAL HEALTH | United States | Public Company | Branded and generic pharmaceutical distribution,Specialty pharmaceutical and manufacturer services,Medical, surgical, and laboratory products (Cardinal brand and national brands), |
| NESTLÉ S.A. | Switzerland | Public Company | Ambient and chilled food (culinary, frozen, chilled, dairy, ice cream),Beverages and coffee (Nescafé, Nespresso, Starbucks At Home, water, drinks),Confectionery and cereals, |
| AVANOS MEDICAL, INC. | United States | Public Company | Digestive health (Mic-Key, Corpak, NeoMed),Non-opioid surgical pain and recovery (ON-Q, ambIT, Game Ready),Interventional pain solutions (COOLIEF, Trident, Esentec RFA), |
| DANONE S.A. | France | Public Company | Essential Dairy & Plant-Based,Specialized Nutrition (Infant & Medical),Waters & Beverages, |
| BOSTON SCIENTIFIC CORPORATION | United States | Public Company | Cardiovascular (structural heart, rhythm management, peripheral),MedSurg Endoscopy (GI, pancreaticobiliary, infection prevention),Urology and Pelvic Health, |
| BECTON, DICKINSON AND COMPANY | United States | Public Company | Medical Essentials (needles, syringes, catheters, sharps, basic disposables),Connected Care (infusion, IV medication safety, dispensing, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems and related solutions), |
| B. BRAUN MELSUNGEN AG | Germany | Private Company | Infusion therapy and smart infusion management,Sterile processing, OR supply, and surgical asset management,Pharma and drug delivery systems (components, systems, clinical trial supplies), |
| CONMED CORPORATION | United States | Public Company | Sports medicine and orthopedic surgery (implants, resection, visualization),Powered instruments (Hall large and small bone systems),General surgery (AirSeal, Buffalo Filter, endomechanical), |
| BAXTER INTERNATIONAL INC. | United States | Public Company | Sterile IV solutions and infusion systems,Generic and specialty injectable pharmaceuticals,Parenteral nutrition and respiratory therapies, |
| ABBOTT | United States | Public Company | Diagnostic Products,Medical Devices,Nutritional Products, |
| MOOG, INC. | United States | Public Company | Space and Defense,Military Aircraft,Commercial Aircraft, |
| TERUMO CORPORATION | Japan | Public Company | Cardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company, |
Wilo SE is a German private company established in 1872 with 8,442 employees, specializing in pump and motor technology.
Fresenius SE & Co. KGaA is a German public company founded in 1912 with 177,783 employees, operating in healthcare and pharmaceutical sectors.
Cardinal Health is a United States public company founded in 1979 with 55,392 employees, serving the healthcare industry.
Nestlé S.A. is a Swiss public company established in 1866 with 271,000 employees, operating as a global food and beverage manufacturer.
Avanos Medical, Inc. is a United States public company founded in 2014 with 2,287 employees in the medical device sector.
Danone S.A. is a French public company established in 1899 with 88,670 employees, specializing in food and beverage products.
Boston Scientific Corporation is a United States public company founded in 1979 with 59,000 employees, developing medical devices and technologies.
Becton, Dickinson and Company is a United States public company established in 1897 with 72,000 employees, manufacturing medical devices and diagnostic products.
B. Braun Melsungen AG is a German private company founded in 1839 with 61,583 employees, operating in the medical and pharmaceutical industries.
Conmed Corporation is a United States public company founded in 1970 with 3,900 employees, specializing in surgical and patient monitoring equipment.
Baxter International Inc. is a United States public company established in 1931 with 37,500 employees, producing medical devices and pharmaceuticals.
Abbott is a United States public company founded in 1888 with 115,000 employees, operating in diagnostics, medical devices, and pharmaceuticals.
Moog, Inc. is a United States public company established in 1951 with 13,500 employees, manufacturing motion control and aerospace components.
Terumo Corporation is a Japanese public company established in 1921 with 30,591 employees, manufacturing medical devices and blood products.
Canada's enteral feeding devices market is valued at $58.3 million in 2025 and is projected to grow to $82.1 million by 2030.
Canada's enteral feeding devices market is growing at a compound annual growth rate (CAGR) of 5.0% from 2025 to 2030.
Key drivers include Canada's aging population, increasing prevalence of chronic diseases, expansion of home-based care services, and strong healthcare infrastructure supporting nutritional support solutions.
Enteral feeding devices are widely used across Canada's hospitals, long-term care facilities, rehabilitation centers, and home care settings for patients requiring nutritional support.
Health Canada oversees enteral feeding devices through its Medical Devices Directorate, ensuring products meet safety and efficacy standards before market approval and distribution.
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, market dynamics, and key player strategies.
The secondary research process involves the comprehensive use of secondary sources, directories, databases (such as Factiva, Bloomberg Businessweek, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the enteral feeding devices market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. Moreover, a database of the key industry leaders was prepared using secondary research.
In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing & sales directors, technology & innovation directors, and related key executives from various companies and organizations in enteral feeding devices market. The primary sources from the demand side include medical OEMs, analytical instrument OEMs, CDMOs, and service providers. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on industry trends & market dynamics.
A breakdown of the primary respondents is provided below:
Note: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = < USD 50 million.
Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
To know about the assumptions considered for the study, download the pdf brochure
In this report, the size of the enteral feeding devices market was determined using revenue analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the enteral feeding device business were determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. Meanwhile, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and marketing executives.
Segmental revenues were calculated based on the revenue mapping of major solution/service providers to calculate the global market value. This process involved the following steps:

After arriving at the overall market size from the market size estimation process explained above, the enteral feeding devices market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the enteral feeding devices market was validated using top-down and bottom-up approaches.
Enteral feeding devices are instruments and configurations designed for nutrition administration directly into the gastrointestinal tract, bypassing the mouth. These devices serve medically challenged patients who cannot eat food orally due to swallowing disorders, severe illnesses, or surgical interferences. Enteral feeding can be accomplished through the insertion of tubes from the nose or mouth, which are then placed into the stomach or small intestine to deliver nutrients.
Full forecast, segment splits, and company analysis for all Enteral Feeding Devices Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report